JB CHEMICALS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 5.87% YoY .
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 4.30 % YoY. |
||
JB CHEMICALS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 506943|NSE : JBCHEPHARM]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹4,148 Cr | ₹3,918 Cr | ₹3,484 Cr | ₹3,149 Cr | ₹2,424 Cr |
| Expenses | ₹3,042 Cr | ₹2,887 Cr | ₹2,592 Cr | ₹2,454 Cr | ₹1,882 Cr |
| Operating Profit (Excl OI) | ₹1,106 Cr | ₹1,031 Cr | ₹892 Cr | ₹696 Cr | ₹543 Cr |
| Other Income | ₹62 Cr | ₹39 Cr | ₹42 Cr | ₹9.94 Cr | ₹40 Cr |
| Interest | ₹5.57 Cr | ₹12 Cr | ₹44 Cr | ₹36 Cr | ₹5.12 Cr |
| Depreciation | ₹182 Cr | ₹171 Cr | ₹138 Cr | ₹114 Cr | ₹73 Cr |
| Profit Before Tax | ₹952 Cr | ₹887 Cr | ₹752 Cr | ₹555 Cr | ₹505 Cr |
| Profit After Tax | ₹709 Cr | ₹660 Cr | ₹553 Cr | ₹410 Cr | ₹386 Cr |
| Consolidated Net Profit | ₹709 Cr | ₹660 Cr | ₹553 Cr | ₹410 Cr | ₹385 Cr |
| Earnings Per Share (Rs) | ₹44.19 | ₹42.37 | ₹35.61 | ₹52.97 | ₹49.86 |
| PAT Margin (%) | 17.71 | 17.47 | 15.33 | 12.54 | 15.51 |
| ROE(%) | 19.11 | 21.81 | 21.49 | 18.51 | 19.89 |
| ROCE(%) | 25.19 | 26.73 | 25.23 | 22.79 | 25.48 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.13 | 0.23 | 0.01 |
Key Financials |
||
| Market Cap | : | ₹ 35,845.9 Cr |
| Revenue (TTM) | : | ₹ 4,147.8 Cr |
| Net Profit(TTM) | : | ₹ 709.5 Cr |
| EPS (TTM) | : | ₹ 44.2 |
| P/E (TTM) | : | 50.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | 1.5% | 0.3% | 30% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 1.8% | 13.4% |
| DIVIS LABORATORIES | -0.2% | -0.1% | 3.1% |
| TORRENT PHARMACEUTICALS | 1.4% | -1.5% | 39.9% |
| CIPLA | 6% | 1.7% | -4.4% |
| DR REDDYS LABORATORIES | 4.8% | -0.3% | -0.9% |
| MANKIND PHARMA | 3% | 0.8% | 7.5% |
| LUPIN | 1.7% | 3.5% | 20.6% |
| ZYDUS LIFESCIENCES | 2.3% | 2.4% | 16.1% |
JB CHEMICALS & PHARMACEUTICALS Revenues
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 5.87 % |
| 5 Yr CAGR | 14.37 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,148 Cr | 5.87 | |
| Mar2025 | ₹3,918 Cr | 12.45 | |
| Mar2024 | ₹3,484 Cr | 10.63 | |
| Mar2023 | ₹3,149 Cr | 29.91 | |
| Mar2022 | ₹2,424 Cr | - | |
JB CHEMICALS & PHARMACEUTICALS Operating Profit
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 7.24 % |
| 5 Yr CAGR | 19.48 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,106 Cr | 7.24 | |
| Mar2025 | ₹1,031 Cr | 15.53 | |
| Mar2024 | ₹892 Cr | 28.28 | |
| Mar2023 | ₹696 Cr | 28.22 | |
| Mar2022 | ₹543 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.29 % |
| 5 Yr CAGR | 4.47 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 26.66% | 1.29 | |
| Mar2025 | 26.32% | 2.73 | |
| Mar2024 | 25.62% | 15.98 | |
| Mar2023 | 22.09% | -1.30 | |
| Mar2022 | 22.38% | - | |
JB CHEMICALS & PHARMACEUTICALS Profit After Tax
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 7.56 % |
| 5 Yr CAGR | 16.48 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹709 Cr | 7.56 | |
| Mar2025 | ₹660 Cr | 19.35 | |
| Mar2024 | ₹553 Cr | 34.84 | |
| Mar2023 | ₹410 Cr | 6.35 | |
| Mar2022 | ₹385 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 1.37 % |
| 5 Yr CAGR | 3.37 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 17.71 % | 1.37 | |
| Mar2025 | 17.47 % | 13.96 | |
| Mar2024 | 15.33 % | 22.25 | |
| Mar2023 | 12.54 % | -19.15 | |
| Mar2022 | 15.51 % | - | |
JB CHEMICALS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | 4.30 % |
| 5 Yr CAGR | -2.97 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 | 4.30 | |
| Mar2025 | ₹42 | 18.98 | |
| Mar2024 | ₹36 | -32.77 | |
| Mar2023 | ₹53 | 6.24 | |
| Mar2022 | ₹50 | - | |
JB CHEMICALS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 506943|NSE : JBCHEPHARM]
| Y-o-Y | -5.76 % |
| 5 Yr CAGR | -0.29 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 25.19% | -5.76 | |
| Mar2025 | 26.73% | 5.95 | |
| Mar2024 | 25.23% | 10.71 | |
| Mar2023 | 22.79% | -10.56 | |
| Mar2022 | 25.48% | - | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹2,232.0 |
| Current MarketCap | : | ₹ 35,845.9 Cr |
| Updated EOD on | : | Jun 24,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | 1.5% |
0.3% |
30% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 3.3% | 2.8% | 12% |
| BSE SMALLCAP SELECT INDEX | 1.6% | 4.4% | 9.6% |
| BSE 250 SMALLCAP INDEX | 1.5% | 5.8% | 3% |
| BSE 400 MIDSMALLCAP INDEX | 0.8% | 3.3% | 4% |
| BSE 1000 | 0.2% | 2.5% | 0.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY PHARMA | 3.6% | 1.8% | 15.7% |
| NIFTY500 HEALTHCARE INDEX | 3.4% | 2.3% | NA |
| NIFTY MIDSMALL HEALTHCARE | 3.4% | 2.1% | 16.5% |
| NIFTY SMALLCAP 250 | 1.7% | 6% | 3.5% |
| NIFTY SMALLCAP 500 | 1.5% | 6.4% | NA |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS Financials
How the annual revenues of JB CHEMICALS & PHARMACEUTICALS have changed ?
The Revenues of JB CHEMICALS & PHARMACEUTICALS have increased by 5.87% YoY .
How the Earnings per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of JB CHEMICALS & PHARMACEUTICALS has increased by 4.30 % YoY .
Check out Intrinsic Value of Peers of JB CHEMICALS & PHARMACEUTICALS
Compare Stock Analytics of Peers of JB CHEMICALS & PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
